EP Energy Corp (NYSE:EPE)
On Thursday, EP Energy Corp (NYSE:EPE)’s shares declined -2.36% to $5.38.
EPE is currently valued at $1.36 billion. The company has 248.80 million shares outstanding and 84.30% shares of the company were owned by institutional investors. The company has 0.46 value in price to sale ratio while price to book ratio was recorded as 0.30. The company exchanged hands with 3.17 million shares as compared to its average daily volume of 3.18 million shares.
The mean estimate for the short term price target for EP Energy Corp (NYSE:EPE) stands at $57.50 according to 4 Analysts. The higher price target estimate for the stock has been calculated at $65.00 while the lower price target estimate is at $42.00.
Analysts mean recommendation for the stock is 2.60. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
EP Energy Corporation is an independent exploration and production company. The Company is engaged in the acquisition and development of unconventional onshore oil and natural gas properties in the United States.
PetroChina Company Limited (ADR) (NYSE:PTR)
PetroChina Company Limited (ADR) (NYSE:PTR)’s shares gained 0.89% to $73.76.
PTR offered 0.70% EPS for prior five years. The company has 5.50% return on equity value while its ROI ratio was 7.70%. The company has $249.51 billion market capitalizations and the institutional ownership was 2.40%. Its price to book ratio was 0.64. Volatility of the stock was 2.20% for the week while for the month booked as 2.07%.
The mean estimate for the short term price target for PetroChina Company Limited (ADR) (NYSE:PTR) stands at $95.46 according to 3 Analysts. The higher price target estimate for the stock has been calculated at $116.08. while the lower price target estimate is at $80.30.00.
Analysts mean recommendation for the stock is 2.70. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
PetroChina Company Limited is an oil and gas producer and seller. The Company operates in four segments: Exploration and Production, Refining and Chemicals, Marketing, and Natural Gas and Pipeline.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
At the end of Thursday’s trade, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)‘s shares dipped -1.93% to $34.97.
ACAD has market value of $3.58 billion while its EPS was booked as $-1.47 in the last 12 months. The stock has 100.91 million shares outstanding while 99.40% shares of the company were owned by institutional investors. Beta value of the company was 3.53; beta is used to measure riskiness of the security.
The mean estimate for the short term price target for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands at $48.70 according to 10 Analysts. The higher price target estimate for the stock has been calculated at $55.00 while the lower price target estimate is at $39.00.
Analysts mean recommendation for the stock is 1.80. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for the treatment of neurological and related central nervous system disorders.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.